BrightHeart, a global leader in artificial intelligence (AI) solutions for obstetrics and pediatric cardiology, recently presented two groundbreaking studies at the Society for Maternal-Fetal Medicine (SMFM) 2025 Pregnancy Meeting, which…
Veradigm Completes Strategic Alternatives Review and Announces Operational Assessment Veradigm® (OTCMKTS: MDRX), a prominent provider of healthcare data and technology solutions, has concluded its previously announced strategic alternatives review, aimed…
Hawthorne Health and RxE2 Partner to Transform Community-Based Clinical Trial Delivery Hawthorne Health, a leader in community-based clinical trial delivery, and RxE2, a pioneer in pharmacist-led clinical trial services, have…
Quanta System, a leader in medical laser technology, is celebrating a significant milestone in 2025: its 40th anniversary. This momentous occasion not only honors the company’s rich history of technological…
Galderma, a global leader in dermatology, is pioneering research into the effects of medication-driven weight loss on the skin and the importance of incorporating aesthetic treatments into the patient journey.…
Senior Care Partners (PACE) Enhances Elderly Patient Safety with DoseMeRx DoseMeRx Empowers Senior Care Partners (PACE) to Improve Elderly Patient Safety with Modernized Vancomycin Dosing DoseMe, a recognized leader in…
VSee Health, Inc. (Nasdaq: VSEE), a prominent leader in digital health services and customized telehealth workflows, recently announced the renewal of a contract valued at approximately $870,000 with a nationwide…
Imperative Care, Inc. has announced that its Zoom System has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). This milestone marks the first comprehensive stroke thrombectomy system…
Merck and Eisai Update on LEAP-015 Trial in Gastroesophageal Cancer Merck (NYSE: MRK), known as MSD outside of the U.S. and Canada, and Eisai have shared results from the Phase…
Patients Benefit from GHLF’s Launch of Interactive Guide for Hidradenitis Suppurativa The Global Healthy Living Foundation (GHLF) has unveiled a new resource aimed at supporting those living with Hidradenitis Suppurativa…
Clinical Data Registry: McKesson’s Practice Insights Named 2025 QCDR by CMS For the ninth year in a row, McKesson has been named a Qualified Clinical Data Registry (QCDR) by the…
Diabetes Breakthrough: IPA Pioneers AI-Designed GLP-1 Therapies ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ: IPA) has pioneered a new class of GLP-1 therapies developed entirely through artificial intelligence, aiming to enhance the…